["{\n\"step_by_step_thinking\": \"The pharmacokinetic profile of isosorbide mononitrate shows that it follows dose-linear kinetics after single and multiple doses. Additionally, the asymmetrical dosage regimen of isosorbide mononitrate provides antianginal efficacy for at least 12 hours without developing tolerance. This suggests that isosorbide mononitrate is preferred because it does not develop tolerance, which is option A.\",\n\"answer_choice\": \"A\"\n}"]